Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PETMED EXPRESS, INC.

(PETS)
  Report
Real-time Estimate Cboe BZX  -  02:57:59 2023-03-24 pm EDT
16.58 USD   -0.81%
03/23Morgan Stanley Adjusts Price Target on PetMed Express to $17 From $18, Maintains Underweight Rating
MT
02/16Top Premarket Decliners
MT
02/16PETMED EXPRESS, INC. : Ex-dividend day for
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

01/17/2023 EDT

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners for $36 million on January 13, 2023. Consideration for all of the issued and outstanding shares of capital stock: (a) $36 million in cash; (b) plus the amount of cash reflected on the final closing statement; and (c) plus any increase or minus any decrease in the adjusted net working capital of Company as reflected on the final closing statement as compared to a mutually agreed upon adjusted net working capital target. The transaction is subject to customary closing conditions and completion of regulatory review.

The deal has been approved by the board of directors of both PetMeds and PetCareRx. PetCareRx Requisite Shareholder Approval. Stockholders of PetCareRx approves the deal.

Following the closing of the transaction, PetMeds intends to keep the consumer facing PetCareRx e-commerce operation and brand running separately. The combined entities will expand PetMeds' existing base of over two million customers and will add approximately 10,000 incremental wellness products to the company's existing product offering. The deal is expected to close in the first quarter of 2023.

CapM Advisors acted as the financial advisor to PetMeds in this transaction. Curt Creely of Foley & Lardner LLP acted as legal advisor to PetMed Express, Inc. Aaron N. Goldberg of Holland & Knight LLP acted as legal advisor to PetMed Express, Inc.


ę S&P Capital IQ 2023
All news about PETMED EXPRESS, INC.
03/23Morgan Stanley Adjusts Price Target on PetMed Express to $17 From $18, Maintains Underw..
MT
02/16Top Premarket Decliners
MT
02/16PETMED EXPRESS, INC. : Ex-dividend day for
FA
02/07PETMED EXPRESS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
02/06Petmed : Fiscal Q3 Earnings Snapshot
AQ
02/06PetMed Express Posts Breakeven Earnings, Lower Sales for Fiscal Q3
MT
02/06Transcript : PetMed Express, Inc., Q3 2023 Earnings Call, Feb 06, 2023
CI
02/06Petmed Express Inc : Results of Operations and Financial Condition, Regulation FD Disclosu..
AQ
02/06Earnings Flash (PETS) PETMED EXPRESS Reports Q3 Revenue $58.9M, vs. Street Est of $62M
MT
02/06PetMeds« Announces Its Third Quarter Financial Results and Declares a Quarterly Dividen..
AQ
More news
Analyst Recommendations on PETMED EXPRESS, INC.
More recommendations
Financials (USD)
Sales 2023 263 M - -
Net income 2023 8,27 M - -
Net cash 2023 96,6 M - -
P/E ratio 2023 41,1x
Yield 2023 7,24%
Capitalization 340 M 340 M -
EV / Sales 2023 0,92x
EV / Sales 2024 0,83x
Nbr of Employees 212
Free-Float 95,7%
Chart PETMED EXPRESS, INC.
Duration : Period :
PetMed Express, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PETMED EXPRESS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 16,71 $
Average target price 19,67 $
Spread / Average Target 17,7%
EPS Revisions
Managers and Directors
Matthew N. Hulett President, Chief Executive Officer & Director
Christine Chambers Chief Financial Officer
Gian Mark Fulgoni Chairman
Mark Moseley Chief Technology & Information Officer
Leslie C. G. Campbell Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PETMED EXPRESS, INC.-5.59%340
RAIA DROGASIL S.A.-0.30%7 401
AIN HOLDINGS INC.-9.11%1 454
QOL HOLDINGS CO., LTD.-2.31%319
NIHON CHOUZAI CO.,LTD.-7.32%254
RITE AID CORPORATION-33.53%130
MarketScreener: Created by Investors for Investors!
100% Free Registration
fermer